Prophylix Pharma

Prophylix Pharma is a Norwegian biotech company focused on developing orphan drugs, including NAITgam for preventing intracranial bleeding

Biotech & Life Sciences

Sector

Seed

Stage

Biotech

Model

01Company Overview

Prophylix Pharma is a Norwegian biotech company focused on developing orphan drugs, including NAITgam for preventing intracranial bleeding. It was founded in 2008 and is involved in clinical trials.

02Backed By1 investor

SSarsia→

03Similar Companies

AC

Is this your company? Claim your profile

Allievex Corp

Biotech & Life Sciences

→

AT

Autifony Therapeutics

Biotech & Life Sciences

→

HT

Hemab Therapeutics

Biotech & Life Sciences

→

C

Chimerix

Biotech & Life Sciences

→

R

River3Renal

Biotech & Life Sciences

→

04Startup DNA

7

signals

Sectors
Business Model
Technology